JUL 21, 2016 7:00 AM PDT

Trace Element Blocks Cancer's Defenses Against Chemo Drugs

WRITTEN BY: Xuan Pham
Chemotherapy is highly effective against cancer when the cancer hasn’t found ways to subvert the treatment. The challenge is that cancer is cunning and can mutate to become resistant to the drugs, resulting in many patient deaths. Now, by combing through molecules that can bypass cancer’s defenses, researchers have stumbled on new compounds that can actually kill multidrug-resistant mouse cancer cells.

Selenium-based compounds block efflux pumps, boost chemo treatments | Image: l120y.com

The compounds are organic and inorganic derivatives of a chemical element known as selenium (atomic number 34). This trace element is essential for normal biological processes, such as reproduction, metabolism, DNA synthesis, and protection from infection. Selenium deficiency can lead to diseases, such as cardiomyopathies (Keshan disease) and bone disorders (Kashin-Beck disease). Furthermore, previous research suggested selenocompounds may have potent anticancer effects.

Indeed, the present study demonstrated selenocompounds prevent cancer cells from becoming resistant to chemotherapeutic drugs, thereby boosting the efficacy of the actual chemotherapy.
In particular, the researchers honed in on how selenocompounds affect the efflux pumps on cells. Normally, the efflux pumps are located on the cell membrane and act to push toxins out of the cells as a protective mechanism. In cancer, the efflux pumps are coerced into pumping out the chemotherapy drugs, which prevent the cancer cells from being killed. Selenocompounds essentially block the efflux pumps from working in cancer cells, thus making the cells susceptible to drugs that were once considered ineffective.
 

"Our research reports a new way to fight multi-drug resistance in cancer,” said Enrique Domínguez-Álvarez, professor at the University of Navarra in Pamplona, and first author of the study. Still, he tempered the team’s results with caution: “We are realistic and we know that much more research needs to be done, but we are excited about these promising results that open new and unexplored possibilities."

So far, the successes of selenocompounds have only been demonstrated on mouse T-lymphoma cells that are resistant to multiple drugs. But the battery of experiments revealed that blocking the efflux pumps led to more cancer cell death; some compounds were reported to kill as much as 80 percent of the mouse cancer cells. These are extremely good news for patients who have the exhausted the list of available drugs to treat their highly resistant cancer.

“The ultimate aim of cancer research is to give more chances to people whose lives are at risk due to this disease. The development of pharmaceutical drugs requires a lot of effort and time, and the results our group presents are just preliminary. But contributing my effort to this fight, even in these starting steps, fulfills me. I hope that in the future our work will serve as the basis to develop new drugs against cancer that reach the patients who need them,” said Domínguez-Álvarez.

Additional source: NIH, Elsevier press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 21, 2019
Cancer
NOV 21, 2019
Inhalable nanoparticle-immunotherapy provides new hope for lung cancer
New research published in Nature Communications details the results of a study that tested inhalable nanoparticle-immunotherapy to determine its impact on ...
DEC 23, 2019
Health & Medicine
DEC 23, 2019
Are Popular Gyms Promoting Indoor Tanning?
You might assume that by now, most humans are aware of the dangers of indoor tanning beds. However, many popular gyms include tanning beds as a perk of mem...
DEC 23, 2019
Cancer
DEC 23, 2019
Sustained weight loss over 50 reduces risk of breast cancer
Research published recently in the Journal of National Cancer Institute suggests a new form of cancer prevention: losing weight and keeping it off. This st...
JAN 08, 2020
Health & Medicine
JAN 08, 2020
Cancer Death Rates Declining in U.S., According to New Report
In the United States, the death rate from cancer has declined, according to a new report released today by the American Cancer Society. The video below sum...
JAN 14, 2020
Cancer
JAN 14, 2020
Could the flu vaccine shrink cancer tumors?
If you’ve been to the doctor recently, you’ve probably been asked if you want a flu shot this year. The flu vaccine is popular because it reduc...
JAN 27, 2020
Genetics & Genomics
JAN 27, 2020
Finding Cancer-Promoting Genes Using Machine Learning
Machine learning algorithms are increasingly being applied to the vast amount of genetic data that has been generated over the past decade....
Loading Comments...